title: Is CT perfusion ready for liver cancer treatment evaluation?
authors.affiliation: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Eleni
authors.initials: E
authors.lastname: Liapi
authors.affiliation: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: mmahesh@jhmi.edu.
authors.forename: Mahadevappa
authors.initials: M
authors.lastname: Mahesh
authors.affiliation: Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Dushyant V
authors.initials: DV
authors.lastname: Sahani
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000639:trends*; D019317:Evidence-Based Medicine; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D055420:Perfusion Imaging / Q000639:trends*; D014057:Tomography, X-Ray Computed / Q000639:trends*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors